Article

Coronavirus and Ophthalmology Best Practices with Rishi Singh, MD

Author(s):

Rishi Singh, MD, of Cole Eye Institute, discusses steps to take to help prevent the spread of coronavirus in ophthalmology practices.

While most elective procedures have been canceled and many practices have temporarily closed as a result of the coronavirus disease 2019 (COVID-19), many ophthalmology practices find themselves in a unique and difficult situation.

With so many ophthalmic procedures directly tied to a patient’s quality of life, some patients may be reluctant to cancel and delay injections or other procedures that may require a specific treatment interval.

Due to the nature of treating ophthalmic conditions and how they require close contact with patients, our sister publication Ophthalmology Times reached out to Rishi Singh, MD, of the Cole Eye Institute at the Cleveland Clinic, for more perspective on steps to take to protect ophthalmologists and their patients.

Related Videos
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
A panel of 3 experts on dry eye
A panel of 3 experts on RVO
HCPLive Five at ASRS 2024 | Image Credit: HCPLive
Jordana Fein, MD: Pre-Dose IOP Outcomes After Aflibercept 8 mg for DME | Image Credit: LinkedIn
Diana Do, MD: Impact of Baseline BCVA on Aflibercept 8 mg Outcomes in DME | Image Credit: Stanford University
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
© 2024 MJH Life Sciences

All rights reserved.